Cardiometabolic risk factors and survival after breast cancer in the Women's Health Initiative

Michael S. Simon, Jennifer L. Beebe-Dimmer, Theresa A. Hastert, Jo Ann E. Manson, Elizabeth M. Cespedes Feliciano, Marian L. Neuhouser, Gloria Y.F. Ho, Jo L. Freudenheim, Howard Strickler, Julie Ruterbusch, Ana Barac, Rowan Chlebowski, Bette Caan

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

BACKGROUND: Few studies have examined the relationship between cardiometabolic risk factors linked to metabolic syndrome and mortality among women with breast cancer. METHODS: We used the Women's Health Initiative to evaluate the relationship between cardiometabolic risk factors, including waist circumference (WC), blood pressure, cholesterol level, and presence of type 2 diabetes, and their relation with death from breast cancer, cardiovascular disease (CVD), and other causes among 8641 women with local or regional stage invasive breast cancer. Cox proportional hazards models were used to estimate hazard ratios, and 95% confidence intervals, adjusted for important predictors of survival. RESULTS: After a median of 11.3 years, there were 2181 total deaths, 619 (28.4%) of which were due to breast cancer. Most participants (55.7%) had at least 2 cardiometabolic risk factors, and 4.9% had 3 or 4. Having a larger number of risk factors was associated with higher risk of CVD and other-cause mortality (P trend <.001 for both), but not with breast cancer mortality (P trend =.86). Increased WC was associated with a higher risk of CVD (hazard ratio [HR], 1.28; 95% confidence interval [CI], 1.05-1.57) and other-cause mortality (HR, 1.32; 95% CI, 1.16-1.49) and only with a small and nonsignificant higher risk of breast cancer mortality (HR, 1.19; 95% CI, 0.93-1.52). The results did not differ in analyses stratified by race, hormone receptor status, or after an analysis of cases diagnosed within 5 years after baseline. CONCLUSIONS: Among women with early stage breast cancer, cardiometabolic risk factors are significantly associated with cardiovascular and other-cause mortality, but not breast cancer mortality. Cancer 2018;124:1798-807.

Original languageEnglish (US)
Pages (from-to)1798-1807
Number of pages10
JournalCancer
Volume124
Issue number8
DOIs
StatePublished - Apr 15 2018
Externally publishedYes

Keywords

  • breast cancer
  • cardiometabolic risk factors
  • survival
  • Women's Health Initiative

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Cardiometabolic risk factors and survival after breast cancer in the Women's Health Initiative'. Together they form a unique fingerprint.

  • Cite this

    Simon, M. S., Beebe-Dimmer, J. L., Hastert, T. A., Manson, J. A. E., Cespedes Feliciano, E. M., Neuhouser, M. L., Ho, G. Y. F., Freudenheim, J. L., Strickler, H., Ruterbusch, J., Barac, A., Chlebowski, R., & Caan, B. (2018). Cardiometabolic risk factors and survival after breast cancer in the Women's Health Initiative. Cancer, 124(8), 1798-1807. https://doi.org/10.1002/cncr.31230